The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In the process, we are changing the way cancer research is conducted. MMRF, a 501(c)(3), is the number one private funder of multiple myeloma research in the United States.
MyMMRF presents a Free Multiple Myeloma Patient Summit: Chicago September 12. Register Now
Join Us for Part 3 in our Free 3-Part Immunotherapy Webinar Series on September 17. Register Today
Get your bib for the world-renowned TCS NYC Marathon, November 1. Register Today
Join Us in New York City! 5K Walk/Run November 21st. Register Today
Collaboration is the only way we do things at the MMRF. Kathy Giusti discusses in her ASCO Post, how the power of collaboration will help make precision medicine a reality.
Read the second post in our blog series on immunotherapy: Boosting the Immune Response. Read More
Connect with patients, engage with experts, get the information you need! MMRF CoMMunity Gateway
At the MMRF, we’re urgently working to develop treatments to extend your life. We can notify you about clinical trials, connect you to other patients with the same disease characteristics, bring you the latest breaking developments, and more. We’re learning every day. You can too.LEARN MORE
The model we have created for drug discovery and development is revolutionary. It brings multiple myeloma treatments to trial 60% faster than average. It has resulted in seven multiple myeloma drugs receiving FDA approval in the time it normally takes for one. Through the power of new technology, genomics and immunology, it has extended lives that would have been lost to multiple myeloma yesterday. And it is accelerating all the time. Learn how we are doing it.